{"transactions":[{"id":741680,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:38.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072934","document":"tm2617547-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072934/tm2617547-9_4seq1.xml","form_type":"4"}},{"id":741679,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:05:27.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072927","document":"tm2617547-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072927/tm2617547-8_4seq1.xml","form_type":"4"}},{"id":741678,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39268,"kind":"person","name":"Hyman Steven","position":1,"cik":"0001656506","reported_name":"Hyman Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:04:30.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072926","document":"tm2617547-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072926/tm2617547-7_4seq1.xml","form_type":"4"}},{"id":741677,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39267,"kind":"person","name":"Vitale Nancy","position":1,"cik":"0001823262","reported_name":"Vitale Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:04:04.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072924","document":"tm2617547-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072924/tm2617547-6_4seq1.xml","form_type":"4"}},{"id":741676,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39266,"kind":"person","name":"Higgins Michael J","position":1,"cik":"0001478521","reported_name":"Higgins Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:03:21.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072923","document":"tm2617547-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072923/tm2617547-5_4seq1.xml","form_type":"4"}},{"id":741917,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":26384,"kind":"person","name":"Onyia Jude","position":1,"cik":"0001894425","reported_name":"Onyia Jude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:02:48.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072922","document":"tm2617547-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894425/000110465926072922/tm2617547-4_4seq1.xml","form_type":"4"}},{"id":741675,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":32747,"kind":"person","name":"GERAGHTY JAMES A","position":1,"cik":"0001239746","reported_name":"GERAGHTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:02:19.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072921","document":"tm2617547-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072921/tm2617547-3_4seq1.xml","form_type":"4"}},{"id":741674,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39265,"kind":"person","name":"Colon Grace","position":1,"cik":"0001780354","reported_name":"Colon Grace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:01:43.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072919","document":"tm2617547-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072919/tm2617547-2_4seq1.xml","form_type":"4"}},{"id":741673,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39264,"kind":"person","name":"PIERCE GLENN","position":1,"cik":"0001256964","reported_name":"PIERCE GLENN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-11T20:01:08.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":30000,"derivative":{"exercise_price":3.43,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-072917","document":"tm2617547-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926072917/tm2617547-1_4seq1.xml","form_type":"4"}},{"id":816296,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-04-03T21:55:27.000Z","date":"2026-04-02","kind":"sale","planned":true,"acquired":false,"shares":11511,"price":3.87,"value":44547.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.81 to $3.95, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":472549,"source":{"system":"sec-edgar","filing":"0001104659-26-039691","document":"tm2611148-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926039691/tm2611148-1_4seq1.xml","form_type":"4"}},{"id":817142,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53916,"kind":"person","name":"Shiferman Gregory L.","position":1,"cik":"0002041689","reported_name":"Shiferman Gregory L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2026-04-03T21:42:56.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 50,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, April 1, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001104659-26-039689","document":"tm2611148-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2041689/000110465926039689/tm2611148-2_4seq1.xml","form_type":"4"}},{"id":879595,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-02-26T14:48:09.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":6458,"price":3.77,"value":24346.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":199738,"source":{"system":"sec-edgar","filing":"0001104659-26-020183","document":"tm267337-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926020183/tm267337-4_4seq1.xml","form_type":"4"}},{"id":879594,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-26T14:47:27.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":14197,"price":3.79,"value":53806.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":484060,"source":{"system":"sec-edgar","filing":"0001104659-26-020181","document":"tm267337-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926020181/tm267337-3_4seq1.xml","form_type":"4"}},{"id":879818,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T14:46:43.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":4668,"price":3.77,"value":17598.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 9, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 9, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":151416,"source":{"system":"sec-edgar","filing":"0001104659-26-020179","document":"tm267337-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465926020179/tm267337-2_4seq1.xml","form_type":"4"}},{"id":879924,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-26T09:44:31.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":4174,"price":3.76,"value":15694.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 21, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.86, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":145718,"source":{"system":"sec-edgar","filing":"0001104659-26-020176","document":"tm267337-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465926020176/tm267337-1_4seq1.xml","form_type":"4"}},{"id":890659,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-02-20T21:04:02.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3882,"price":3.44,"value":13354.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.47, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":206196,"source":{"system":"sec-edgar","filing":"0001104659-26-018131","document":"tm266896-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926018131/tm266896-3_4seq1.xml","form_type":"4"}},{"id":890658,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-20T21:01:23.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":11732,"price":3.41,"value":40006.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.47, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":498257,"source":{"system":"sec-edgar","filing":"0001104659-26-018126","document":"tm266896-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926018126/tm266896-1_4seq1.xml","form_type":"4"}},{"id":890948,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-20T16:03:26.000Z","date":"2026-02-18","kind":"sale","planned":true,"acquired":false,"shares":3301,"price":3.44,"value":11355.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock of Voyager Therapeutics, Inc. (the \"Corporation\") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on May 12, 2025, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.40 to $3.47, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":149892,"source":{"system":"sec-edgar","filing":"0001104659-26-018130","document":"tm266896-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465926018130/tm266896-2_4seq1.xml","form_type":"4"}},{"id":909908,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-02-11T21:32:27.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":4569,"price":3.85,"value":17590.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.72 to $3.90, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":210078,"source":{"system":"sec-edgar","filing":"0001104659-26-013416","document":"tm266069-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926013416/tm266069-3_4seq1.xml","form_type":"4"}},{"id":909904,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-11T21:30:56.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":12192,"price":3.78,"value":46085.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.68 to $3.91, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":509989,"source":{"system":"sec-edgar","filing":"0001104659-26-013414","document":"tm266069-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926013414/tm266069-2_4seq1.xml","form_type":"4"}},{"id":910169,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-11T16:30:40.000Z","date":"2026-02-10","kind":"sale","planned":false,"acquired":false,"shares":3525,"price":3.85,"value":13571.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2026. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.71 to $3.91, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":153193,"source":{"system":"sec-edgar","filing":"0001104659-26-013408","document":"tm266069-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465926013408/tm266069-1_4seq1.xml","form_type":"4"}},{"id":911841,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T21:31:39.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 6, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":210000,"derivative":{"exercise_price":3.68,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001104659-26-012675","document":"tm265871-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926012675/tm265871-3_4seq1.xml","form_type":"4"}},{"id":911840,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2026-02-10T21:31:39.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 45,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 6, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":214647,"source":{"system":"sec-edgar","filing":"0001104659-26-012675","document":"tm265871-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926012675/tm265871-3_4seq1.xml","form_type":"4"}},{"id":911839,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T21:30:53.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":402500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 6, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":402500,"derivative":{"exercise_price":3.68,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":402500},"source":{"system":"sec-edgar","filing":"0001104659-26-012672","document":"tm265871-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926012672/tm265871-2_4seq1.xml","form_type":"4"}},{"id":911838,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:53.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":86250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 86,250 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 6, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,000 shares of common stock acquired under the Voyager Therapeutics, Inc. Amended and Restated 2015 Employee Stock Purchase Plan since the date of the reporting person's last Form 4."}],"balance_after":522181,"source":{"system":"sec-edgar","filing":"0001104659-26-012672","document":"tm265871-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465926012672/tm265871-2_4seq1.xml","form_type":"4"}},{"id":912188,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T21:30:15.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":150500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 6, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":150500,"derivative":{"exercise_price":3.68,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":150500},"source":{"system":"sec-edgar","filing":"0001104659-26-012669","document":"tm265871-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465926012669/tm265871-1_4seq1.xml","form_type":"4"}},{"id":912187,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-10T21:30:15.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":32250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 32,250 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 6, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":156084,"source":{"system":"sec-edgar","filing":"0001104659-26-012669","document":"tm265871-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465926012669/tm265871-1_4seq1.xml","form_type":"4"}},{"id":912391,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:33:26.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 6, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":210000,"derivative":{"exercise_price":3.68,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001104659-26-012679","document":"tm265871-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465926012679/tm265871-5_4seq1.xml","form_type":"4"}},{"id":912390,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-10T16:33:26.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 45,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 6, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":183914,"source":{"system":"sec-edgar","filing":"0001104659-26-012679","document":"tm265871-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465926012679/tm265871-5_4seq1.xml","form_type":"4"}},{"id":912305,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T16:32:54.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":154000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 6, 2026. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":154000,"derivative":{"exercise_price":3.68,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":154000},"source":{"system":"sec-edgar","filing":"0001104659-26-012677","document":"tm265871-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465926012677/tm265871-4_4seq1.xml","form_type":"4"}},{"id":912304,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-10T16:32:54.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 33,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 6, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":156718,"source":{"system":"sec-edgar","filing":"0001104659-26-012677","document":"tm265871-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465926012677/tm265871-4_4seq1.xml","form_type":"4"}},{"id":943428,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53916,"kind":"person","name":"Shiferman Gregory L.","position":1,"cik":"0002041689","reported_name":"Shiferman Gregory L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T23:10:46.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option was granted pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee."}],"balance_after":100000,"derivative":{"exercise_price":4.02,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-002225","document":"tm262553-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2041689/000110465926002225/tm262553-2_4seq1.xml","form_type":"4"}},{"id":1022268,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-07T20:30:38.000Z","date":"2025-10-03","kind":"sale","planned":true,"acquired":false,"shares":7666,"price":4.78,"value":36643.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter adopted by the reporting person on May 9, 2025 effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on October 3, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter adopted by the reporting person on May 9, 2025 effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on October 3, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.74 to $4.85, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":123834,"source":{"system":"sec-edgar","filing":"0001104659-25-097522","document":"tm2528202d1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465925097522/tm2528202d1_4seq1.xml","form_type":"4"}},{"id":1060470,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-08-20T14:09:54.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":19000,"price":3.73,"value":70870.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.69 to $3.79, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":138914,"source":{"system":"sec-edgar","filing":"0001104659-25-080825","document":"tm2524007-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465925080825/tm2524007-1_4seq1.xml","form_type":"4"}},{"id":1122867,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39267,"kind":"person","name":"Vitale Nancy","position":1,"cik":"0001823262","reported_name":"Vitale Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:09:17.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056568","document":"tm2517191-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056568/tm2517191-9_4seq1.xml","form_type":"4"}},{"id":1122866,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:08:12.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056567","document":"tm2517191-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056567/tm2517191-8_4seq1.xml","form_type":"4"}},{"id":1122865,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39264,"kind":"person","name":"PIERCE GLENN","position":1,"cik":"0001256964","reported_name":"PIERCE GLENN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:07:12.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056566","document":"tm2517191-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056566/tm2517191-7_4seq1.xml","form_type":"4"}},{"id":1123165,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":26384,"kind":"person","name":"Onyia Jude","position":1,"cik":"0001894425","reported_name":"Onyia Jude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:04:35.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056565","document":"tm2517191-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894425/000110465925056565/tm2517191-6_4seq1.xml","form_type":"4"}},{"id":1122864,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:03:21.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056564","document":"tm2517191-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056564/tm2517191-5_4seq1.xml","form_type":"4"}},{"id":1122863,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39268,"kind":"person","name":"Hyman Steven","position":1,"cik":"0001656506","reported_name":"Hyman Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:02:01.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056563","document":"tm2517191-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056563/tm2517191-4_4seq1.xml","form_type":"4"}},{"id":1122862,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39266,"kind":"person","name":"Higgins Michael J","position":1,"cik":"0001478521","reported_name":"Higgins Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T01:00:45.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056562","document":"tm2517191-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056562/tm2517191-3_4seq1.xml","form_type":"4"}},{"id":1122860,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":32747,"kind":"person","name":"GERAGHTY JAMES A","position":1,"cik":"0001239746","reported_name":"GERAGHTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T00:59:43.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056560","document":"tm2517191-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056560/tm2517191-2_4seq1.xml","form_type":"4"}},{"id":1122861,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39265,"kind":"person","name":"Colon Grace","position":1,"cik":"0001780354","reported_name":"Colon Grace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-05T00:58:05.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2025 Stock Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":3.28,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-25-056559","document":"tm2517191-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925056559/tm2517191-1_4seq1.xml","form_type":"4"}},{"id":1177593,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-04-04T20:08:51.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":10885,"price":3.43,"value":37335.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.52, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":430931,"source":{"system":"sec-edgar","filing":"0001104659-25-032202","document":"tm2511532-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925032202/tm2511532-1_4seq1.xml","form_type":"4"}},{"id":1177798,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-04-04T16:10:01.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":10086,"price":3.43,"value":34594.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.51, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":157914,"source":{"system":"sec-edgar","filing":"0001104659-25-032208","document":"tm2511532-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465925032208/tm2511532-2_4seq1.xml","form_type":"4"}},{"id":1249517,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T21:20:38.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":290000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 21, 2025. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":290000,"derivative":{"exercise_price":4.22,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":290000},"source":{"system":"sec-edgar","filing":"0001104659-25-016520","document":"tm257355-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016520/tm257355-5_4seq1.xml","form_type":"4"}},{"id":1249516,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-24T21:20:38.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":145000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock issuable under an aggregate of 145,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 21, 2025. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":441816,"source":{"system":"sec-edgar","filing":"0001104659-25-016520","document":"tm257355-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016520/tm257355-5_4seq1.xml","form_type":"4"}},{"id":1249515,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-24T21:20:38.000Z","date":"2025-02-20","kind":"sale","planned":false,"acquired":false,"shares":11702,"price":4.24,"value":49616.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.32, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":296816,"source":{"system":"sec-edgar","filing":"0001104659-25-016520","document":"tm257355-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016520/tm257355-5_4seq1.xml","form_type":"4"}},{"id":1249514,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T21:19:33.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":142500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 21, 2025. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":142500,"derivative":{"exercise_price":4.22,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":142500},"source":{"system":"sec-edgar","filing":"0001104659-25-016516","document":"tm257355-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016516/tm257355-4_4seq1.xml","form_type":"4"}},{"id":1249513,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-02-24T21:19:33.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":71250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock issuable under an aggregate of 71,250 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 21, 2025. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":169647,"source":{"system":"sec-edgar","filing":"0001104659-25-016516","document":"tm257355-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016516/tm257355-4_4seq1.xml","form_type":"4"}},{"id":1249512,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-02-24T21:19:33.000Z","date":"2025-02-20","kind":"sale","planned":false,"acquired":false,"shares":3894,"price":4.25,"value":16549.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.22 to $4.33, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":98397,"source":{"system":"sec-edgar","filing":"0001104659-25-016516","document":"tm257355-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016516/tm257355-4_4seq1.xml","form_type":"4"}},{"id":1249511,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":82878,"kind":"person","name":"Fahey Sandell Jacquelyn","position":1,"cik":"0001984647","reported_name":"Fahey Sandell Jacquelyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T21:18:00.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":83000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 21, 2025. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":83000,"derivative":{"exercise_price":4.22,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":83000},"source":{"system":"sec-edgar","filing":"0001104659-25-016515","document":"tm257355-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016515/tm257355-3_4seq1.xml","form_type":"4"}},{"id":1249510,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":82878,"kind":"person","name":"Fahey Sandell Jacquelyn","position":1,"cik":"0001984647","reported_name":"Fahey Sandell Jacquelyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-24T21:18:00.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":41500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 41,500 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 21, 2025. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":123143,"source":{"system":"sec-edgar","filing":"0001104659-25-016515","document":"tm257355-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925016515/tm257355-3_4seq1.xml","form_type":"4"}},{"id":1249839,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T21:15:51.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":103000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 21, 2025. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":103000,"derivative":{"exercise_price":4.22,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":103000},"source":{"system":"sec-edgar","filing":"0001104659-25-016510","document":"tm257355-1_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465925016510/tm257355-1_4seq.xml","form_type":"4"}},{"id":1249838,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-24T21:15:51.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":51500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 51,500 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 21, 2025. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":131500,"source":{"system":"sec-edgar","filing":"0001104659-25-016510","document":"tm257355-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465925016510/tm257355-1_4seq.xml","form_type":"4"}},{"id":1249958,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T16:21:45.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":92000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 21, 2025. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":92000,"derivative":{"exercise_price":4.22,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":92000},"source":{"system":"sec-edgar","filing":"0001104659-25-016522","document":"tm257355-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465925016522/tm257355-6_4seq1.xml","form_type":"4"}},{"id":1249957,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-24T16:21:45.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares of common stock issuable under an aggregate of 46,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 21, 2025. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":123718,"source":{"system":"sec-edgar","filing":"0001104659-25-016522","document":"tm257355-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465925016522/tm257355-6_4seq1.xml","form_type":"4"}},{"id":1249956,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-24T16:21:45.000Z","date":"2025-02-20","kind":"sale","planned":false,"acquired":false,"shares":3305,"price":4.26,"value":14079.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.39, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":77718,"source":{"system":"sec-edgar","filing":"0001104659-25-016522","document":"tm257355-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465925016522/tm257355-6_4seq1.xml","form_type":"4"}},{"id":1250011,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-24T16:16:56.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 21, 2025. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":126000,"derivative":{"exercise_price":4.22,"expiration_date":"2035-02-21","underlying":"Common Stock","underlying_shares":126000},"source":{"system":"sec-edgar","filing":"0001104659-25-016512","document":"tm257355-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465925016512/tm257355-2_4seq1.xml","form_type":"4"}},{"id":1250010,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-24T16:16:56.000Z","date":"2025-02-21","kind":"grant","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 63,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 21, 2025. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":168000,"source":{"system":"sec-edgar","filing":"0001104659-25-016512","document":"tm257355-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465925016512/tm257355-2_4seq1.xml","form_type":"4"}},{"id":1271636,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-02-12T21:21:17.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":6950,"price":4.45,"value":30927.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $5.00, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":102291,"source":{"system":"sec-edgar","filing":"0001104659-25-012198","document":"tm256369-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925012198/tm256369-3_4seq1.xml","form_type":"4"}},{"id":1271635,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-02-12T21:20:21.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":16644,"price":4.45,"value":74065.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $5.00, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,323 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan since the date of the reporting person's last Form 4."}],"balance_after":308518,"source":{"system":"sec-edgar","filing":"0001104659-25-012196","document":"tm256369-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925012196/tm256369-2_4seq1.xml","form_type":"4"}},{"id":1271634,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":82878,"kind":"person","name":"Fahey Sandell Jacquelyn","position":1,"cik":"0001984647","reported_name":"Fahey Sandell Jacquelyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:19:21.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":4358,"price":4.45,"value":19393.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $5.00, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":81643,"source":{"system":"sec-edgar","filing":"0001104659-25-012195","document":"tm256369-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925012195/tm256369-1_4seq1.xml","form_type":"4"}},{"id":1271958,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-12T16:22:10.000Z","date":"2025-02-11","kind":"sale","planned":false,"acquired":false,"shares":5413,"price":4.45,"value":24087.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 9, 2025. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $5.00, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":81023,"source":{"system":"sec-edgar","filing":"0001104659-25-012200","document":"tm256369-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465925012200/tm256369-4_4seq1.xml","form_type":"4"}},{"id":1302576,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO & CBO"}}],"security":"Common Stock","published_at":"2025-01-15T21:18:24.000Z","date":"2025-01-14","kind":"sale","planned":false,"acquired":false,"shares":3087,"price":5.09,"value":15712.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.05 to $5.23, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":109241,"source":{"system":"sec-edgar","filing":"0001104659-25-003773","document":"tm253408-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465925003773/tm253408-2_4seq1.xml","form_type":"4"}},{"id":1302740,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-01-15T16:17:55.000Z","date":"2025-01-14","kind":"sale","planned":false,"acquired":false,"shares":1191,"price":5.13,"value":6109.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.05 to $5.30, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":86436,"source":{"system":"sec-edgar","filing":"0001104659-25-003772","document":"tm253408-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465925003772/tm253408-1_4seq1.xml","form_type":"4"}},{"id":1321649,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"COO&CBO"}}],"security":"Common Stock","published_at":"2024-12-26T21:29:44.000Z","date":"2024-12-23","kind":"sale","planned":false,"acquired":false,"shares":6500,"price":5.65,"value":36725.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.62 to $5.70, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,824 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan on June 28, 2024."}],"balance_after":112328,"source":{"system":"sec-edgar","filing":"0001104659-24-131725","document":"tm2431995-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924131725/tm2431995-1_4seq1.xml","form_type":"4"}},{"id":1391916,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":82878,"kind":"person","name":"Fahey Sandell Jacquelyn","position":1,"cik":"0001984647","reported_name":"Fahey Sandell Jacquelyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-10-03T20:43:34.000Z","date":"2024-10-02","kind":"sale","planned":false,"acquired":false,"shares":5999,"price":5.82,"value":34914.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on October 1, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on October 1, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.77 to $5.88, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":86001,"source":{"system":"sec-edgar","filing":"0001104659-24-105885","document":"tm2425529-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924105885/tm2425529-1_4seq1.xml","form_type":"4"}},{"id":1394669,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-02T20:09:19.000Z","date":"2024-10-01","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This equity award was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the \"Company\"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4)."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock underlying a restricted stock unit (\"RSU\") award. Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is October 1, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting upon the one-year anniversary of such vesting commencement date and the remainder vesting in equal annual installments thereafter, subject to the Reporting Person's continued service as an employee."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001104659-24-105438","document":"tm2425390-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465924105438/tm2425390-1_4seq1.xml","form_type":"4"}},{"id":1457680,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64504,"kind":"person","name":"Jorgensen Nathan D.","position":1,"cik":"0001842523","reported_name":"Jorgensen Nathan D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-09T20:11:23.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the \"Company\"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee."}],"balance_after":200000,"derivative":{"exercise_price":7.79,"expiration_date":"2034-07-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001104659-24-078547","document":"tm2419082-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1842523/000110465924078547/tm2419082-2_4seq1.xml","form_type":"4"}},{"id":1486742,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39267,"kind":"person","name":"Vitale Nancy","position":1,"cik":"0001823262","reported_name":"Vitale Nancy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:22:47.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069667","document":"tm2416702-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069667/tm2416702-9_4seq1.xml","form_type":"4"}},{"id":1486741,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39269,"kind":"person","name":"SCANGOS GEORGE A","position":1,"cik":"0001202102","reported_name":"SCANGOS GEORGE A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:21:53.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069666","document":"tm2416702-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069666/tm2416702-8_4seq1.xml","form_type":"4"}},{"id":1486740,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39264,"kind":"person","name":"PIERCE GLENN","position":1,"cik":"0001256964","reported_name":"PIERCE GLENN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:20:49.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069665","document":"tm2416702-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069665/tm2416702-7_4seq1.xml","form_type":"4"}},{"id":1487168,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":26384,"kind":"person","name":"Onyia Jude","position":1,"cik":"0001894425","reported_name":"Onyia Jude","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:20:15.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069664","document":"tm2416702-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1894425/000110465924069664/tm2416702-6_4seq1.xml","form_type":"4"}},{"id":1486739,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":36683,"kind":"person","name":"MACKEY CATHERINE J","position":1,"cik":"0001645330","reported_name":"MACKEY CATHERINE J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:19:25.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069662","document":"tm2416702-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069662/tm2416702-5_4seq1.xml","form_type":"4"}},{"id":1486738,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39268,"kind":"person","name":"Hyman Steven","position":1,"cik":"0001656506","reported_name":"Hyman Steven","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:17:50.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069659","document":"tm2416702-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069659/tm2416702-4_4seq1.xml","form_type":"4"}},{"id":1486737,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39266,"kind":"person","name":"Higgins Michael J","position":1,"cik":"0001478521","reported_name":"Higgins Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:16:51.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069658","document":"tm2416702-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069658/tm2416702-3_4seq1.xml","form_type":"4"}},{"id":1486736,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":32747,"kind":"person","name":"GERAGHTY JAMES A","position":1,"cik":"0001239746","reported_name":"GERAGHTY JAMES A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:15:45.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069656","document":"tm2416702-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069656/tm2416702-2_4seq1.xml","form_type":"4"}},{"id":1486735,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":39265,"kind":"person","name":"Colon Grace","position":1,"cik":"0001780354","reported_name":"Colon Grace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T20:15:13.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was issued pursuant to the 2015 Stock Option and Incentive Plan of Voyager Therapeutics, Inc. in accordance with its director compensation policy. The vesting commencement date (the \"Vesting Commencement Date\") of the option is the grant date. All of the shares of common stock underlying the option vest upon the earlier of the one-year anniversary of the Vesting Commencement Date or the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service as a director."}],"balance_after":24000,"derivative":{"exercise_price":8.7,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-24-069650","document":"tm2416702-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924069650/tm2416702-1_4seq1.xml","form_type":"4"}},{"id":1549567,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-04-03T20:13:27.000Z","date":"2024-04-02","kind":"sale","planned":false,"acquired":false,"shares":1357,"price":9.88,"value":13407.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.83 to $10.01, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":117004,"source":{"system":"sec-edgar","filing":"0001104659-24-043107","document":"tm2410775-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924043107/tm2410775-2_4seq1.xml","form_type":"4"}},{"id":1549565,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-04-03T20:10:41.000Z","date":"2024-04-02","kind":"sale","planned":false,"acquired":false,"shares":12115,"price":9.86,"value":119453.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on April 1, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.71 to $10.02, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":322839,"source":{"system":"sec-edgar","filing":"0001104659-24-043104","document":"tm2410775-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924043104/tm2410775-1_4seq1.xml","form_type":"4"}},{"id":1550539,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-04-03T16:17:01.000Z","date":"2024-04-01","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This equity award was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the \"Company\"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4)."},{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of shares of common stock underlying a restricted stock unit (\"RSU\") award. Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is April 1, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting upon the one-year anniversary of such vesting commencement date and the remainder vesting in equal annual installments thereafter, subject to the Reporting Person's continued service as an employee."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001104659-24-043111","document":"tm2410775-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465924043111/tm2410775-3_4seq1.xml","form_type":"4"}},{"id":1560819,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":67070,"kind":"person","name":"Ferguson Toby","position":1,"cik":"0002015616","reported_name":"Ferguson Toby","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-26T17:27:55.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option was not granted pursuant to any pre-existing equity incentive plan of Voyager Therapeutics, Inc. (the \"Company\"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date of the option is the grant date. The option vests over four years, with 1/4th of the shares of common stock underlying the option vesting upon the one-year anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service as an employee."}],"balance_after":210000,"derivative":{"exercise_price":9.26,"expiration_date":"2034-03-25","underlying":"Common Stock","underlying_shares":210000},"source":{"system":"sec-edgar","filing":"0001104659-24-039117","document":"tm249758-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2015616/000110465924039117/tm249758-2_4seq1.xml","form_type":"4"}},{"id":1625347,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:36:22.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":3966,"price":7.45,"value":29546.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.36 to $7.52, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":118361,"source":{"system":"sec-edgar","filing":"0001104659-24-026562","document":"tm246990-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924026562/tm246990-4_4seq1.xml","form_type":"4"}},{"id":1625346,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-22T21:34:47.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":13033,"price":7.46,"value":97226.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.35 to $7.55, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":334954,"source":{"system":"sec-edgar","filing":"0001104659-24-026561","document":"tm246990-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924026561/tm246990-3_4seq1.xml","form_type":"4"}},{"id":1625345,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":75195,"kind":"person","name":"PFREUNDSCHUH PETER P.","position":1,"cik":"0001585839","reported_name":"PFREUNDSCHUH PETER P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:32:59.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":3764,"price":7.46,"value":28079.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.54, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":175669,"source":{"system":"sec-edgar","filing":"0001104659-24-026556","document":"tm246990-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924026556/tm246990-2_4seq1.xml","form_type":"4"}},{"id":1625791,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-22T16:30:55.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":3365,"price":7.47,"value":25136.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 17, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.54, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4."}],"balance_after":87627,"source":{"system":"sec-edgar","filing":"0001104659-24-026554","document":"tm246990d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465924026554/tm246990d1_4.xml","form_type":"4"}},{"id":1625790,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-22T16:30:55.000Z","date":"2024-02-20","kind":"sale","planned":false,"acquired":false,"shares":602,"price":7.68,"value":4623.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 16, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on February 16, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.76, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":90992,"source":{"system":"sec-edgar","filing":"0001104659-24-026554","document":"tm246990d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465924026554/tm246990d1_4.xml","form_type":"4"}},{"id":1638204,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":82878,"kind":"person","name":"Fahey Sandell Jacquelyn","position":1,"cik":"0001984647","reported_name":"Fahey Sandell Jacquelyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T22:06:56.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":62000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 9, 2024. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":62000,"derivative":{"exercise_price":7.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":62000},"source":{"system":"sec-edgar","filing":"0001104659-24-024998","document":"tm246517-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024998/tm246517-5_4seq1.xml","form_type":"4"}},{"id":1638203,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":82878,"kind":"person","name":"Fahey Sandell Jacquelyn","position":1,"cik":"0001984647","reported_name":"Fahey Sandell Jacquelyn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2024-02-16T22:06:56.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 31,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 9, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":92000,"source":{"system":"sec-edgar","filing":"0001104659-24-024998","document":"tm246517-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024998/tm246517-5_4seq1.xml","form_type":"4"}},{"id":1638202,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T22:03:00.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 9, 2024. The option vests over four years, with 1/48th of the shares of common stock\nunderlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each\nsuccessive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":100000,"derivative":{"exercise_price":7.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-024989","document":"tm246517-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024989/tm246517-3_4seq1.xml","form_type":"4"}},{"id":1638201,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-02-16T22:03:00.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 50,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and\nIncentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 9, 2024. The RSU\naward vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of\ncommon stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":122327,"source":{"system":"sec-edgar","filing":"0001104659-24-024989","document":"tm246517-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024989/tm246517-3_4seq1.xml","form_type":"4"}},{"id":1638200,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T21:59:48.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 9, 2024. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":260000,"derivative":{"exercise_price":7.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0001104659-24-024982","document":"tm246517-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024982/tm246517-2_4seq1.xml","form_type":"4"}},{"id":1638199,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":53833,"kind":"person","name":"Sandrock Alfred","position":1,"cik":"0001577061","reported_name":"Sandrock Alfred","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-16T21:59:48.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 130,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 9, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,369 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan since the date of the reporting person's last Form 4."}],"balance_after":347987,"source":{"system":"sec-edgar","filing":"0001104659-24-024982","document":"tm246517-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024982/tm246517-2_4seq1.xml","form_type":"4"}},{"id":1638198,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":75195,"kind":"person","name":"PFREUNDSCHUH PETER P.","position":1,"cik":"0001585839","reported_name":"PFREUNDSCHUH PETER P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T21:58:45.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 9, 2024. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":60000,"derivative":{"exercise_price":7.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-24-024981","document":"tm246517-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024981/tm246517-1_4seq1.xml","form_type":"4"}},{"id":1638197,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":75195,"kind":"person","name":"PFREUNDSCHUH PETER P.","position":1,"cik":"0001585839","reported_name":"PFREUNDSCHUH PETER P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-16T21:58:45.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 30,000 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 9, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":179433,"source":{"system":"sec-edgar","filing":"0001104659-24-024981","document":"tm246517-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924024981/tm246517-1_4seq1.xml","form_type":"4"}},{"id":1638660,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-16T17:04:45.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":77000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option was issued pursuant to the Plan. The vesting commencement date of the option is the grant date, February 9, 2024. The option vests over four years, with 1/48th of the shares of common stock underlying the option vesting upon the one-month anniversary of such vesting commencement date and an additional 1/48th of the shares of common stock underlying the option vesting at the end of each successive one-month period thereafter, subject to the Reporting Person's continued service."}],"balance_after":77000,"derivative":{"exercise_price":7.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":77000},"source":{"system":"sec-edgar","filing":"0001104659-24-024993","document":"tm246517-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465924024993/tm246517-4_4seq1.xml","form_type":"4"}},{"id":1638659,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-16T17:04:45.000Z","date":"2024-02-09","kind":"grant","planned":false,"acquired":true,"shares":38500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of shares of common stock issuable under an aggregate of 38,500 restricted stock units (\"RSUs\") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan (the \"Plan\"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, February 9, 2024. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service."}],"balance_after":91594,"source":{"system":"sec-edgar","filing":"0001104659-24-024993","document":"tm246517-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465924024993/tm246517-4_4seq1.xml","form_type":"4"}},{"id":1675182,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64479,"kind":"person","name":"Swartz Robin","position":1,"cik":"0001909636","reported_name":"Swartz Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2024-01-19T21:34:25.000Z","date":"2024-01-17","kind":"sale","planned":false,"acquired":false,"shares":2543,"price":7.15,"value":18182.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 13, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 13, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 to $7.27, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,253 shares of common stock acquired under the Voyager Therapeutics, Inc. 2015 Employee Stock Purchase Plan since the date of the reporting person's last Form 4."}],"balance_after":72327,"source":{"system":"sec-edgar","filing":"0001104659-24-005247","document":"tm243664-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1640266/000110465924005247/tm243664-2_4seq1.xml","form_type":"4"}},{"id":1675426,"issuer":{"id":6271,"kind":"organization","name":"Voyager Therapeutics, Inc."},"owners":[{"id":64511,"kind":"person","name":"Carter Todd Alfred","position":1,"cik":"0001944011","reported_name":"Carter Todd Alfred","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-19T16:32:36.000Z","date":"2024-01-17","kind":"sale","planned":false,"acquired":false,"shares":1266,"price":7.18,"value":9089.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 13, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on January 13, 2024. The sales do not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.04 to $7.27, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":53094,"source":{"system":"sec-edgar","filing":"0001104659-24-005244","document":"tm243664-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1944011/000110465924005244/tm243664-1_4seq1.xml","form_type":"4"}}],"next_cursor":"2024-01-19T16:32:36.000000Z,1675426"}